Struggles with clinical translation of immune intervention trials.
Corresponding author: Jay S. Skyler, jskyler@med.miami.edu.
Jay S
JS
Skyler
D018834:Chaperonin 60 / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D005502:Food; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D005934:Glucagon / Q000494:pharmacology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*
D018834:Chaperonin 60; D005765:Gastrointestinal Agents; D007004:Hypoglycemic Agents; D010446:Peptide Fragments; D005934:Glucagon